Furthermore, the nuclear PKC-θ+/CSV+/ABCB5+ phenotype represented a higher proportion of the total tumor cell population in brain metastases from breast cancer patients (median 32.4%) compared with primary breast tumors (median 13.1%), indicating an association of this phenotype with tumor metastasis (Figure 1F). Here, PRRT2 is linked to breast carcinoma.